Deerfield finances pioneer in 3D printing for pharmaceuticals

Published: 29-Jan-2016
Manufacturing Drug Delivery Research & Development Finance Pharmaceutical Dosage Forms

Proceeds from the financing will allow Aprecia to launch SPRITAM, the first 3D printed medicine approved by the US Food and Drug Administration


Deerfield Management Company has invested US$30m to lead a $35m financing in Aprecia Pharmaceuticals.

Proceeds from this financing will allow Aprecia to launch SPRITAM, the first 3D printed medicine approved by the US Food and Drug Administration, as well as accelerate the development of additional 3D printed drug formulations using Aprecia's novel 3DP technology platform.

Aprecia is a speciality pharmaceutical company using its proprietary 3D printing technology platform to develop and manufacture pharmaceuticals. The company's ZipDose formulation platform enables the production of rapidly dissolving dosage forms that may exceed the formulation limits of existing fast-melt technologies. SPRITAM is an oral fast-melt form of levetiracetam for epilepsy.

‘Based on extensive market research conducted by the Deerfield Institute, we believe there is a substantial population of epilepsy patients, particularly children, who are not well served by existing formulations and will benefit from SPRITAM and the other epilepsy drugs in Aprecia's pipeline,’ said Jonathan Leff, Partner at Deerfield.

‘We are very pleased to join with the Aprecia team to advance the commercialisation of important new therapies based on the company's unique 3D printing technology,’ he added.

‘We are excited to have Deerfield as our partner in the launch of SPRITAM. Deerfield has demonstrated tremendous knowledge of the field as well as creativity and flexibility in structuring the financing. With its desire to advance healthcare and address unmet patient needs, we believe Deerfield is an ideal partner for Aprecia,’ said Don Wetherhold, CEO of Aprecia.

See more

You may also like

Manufacturing

Aprecia and Battelle partner on 3D printing

Read more
The collaboration will aim to advance 3D printing equipment from clinical supply through commercial scale, while increasing manufacturing throughput and efficiency at every level

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
  2. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  3. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    How CDMOs can set a new gold standard when it comes to going green Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards positive change, reports Tim Lowery, President of JSR Life Sciences and CEO, KBI Biopharma

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Aprecia and Battelle partner on 3D printing

The collaboration will aim to advance 3D printing equipment from clinical supply through commercial scale, while increasing manufacturing throughput and efficiency at every level
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

A new dimension in drug manufacturing

The FDA approval of the first 3D printed drug for public use signals changes ahead for the pharma manufacturing sector
You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

Designer pills and smart capsules that can deliver

Oral delivery of drugs remains a preferred route, and innovation in this field is at its most creative. Dr Sarah Houlton looks at some of the interesting options under development
Drug Delivery

US FDA approves first 3D printed drug product

Aprecia uses the proprietary ZipDose technology to manufacture a treatment to control seizures in epilepsy
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

How CDMOs can set a new gold standard when it comes to going green

Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards positive change, reports Tim Lowery, President of JSR Life Sciences and CEO, KBI Biopharma
Finance

Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China

New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
Research & Development

Thermo Fisher Scientific reveals MagMax Sequential DNA/RNA Kit to advance blood cancer research

The kit combines DNA and RNA isolation chemistries into a single kit, simplifying sample extraction for a broad range of downstream molecular applications
Subscribe now